76 related articles for article (PubMed ID: 9275471)
1. [Analysis of telomere restriction fragments in human astrocytomas and glioblastomas].
Liu J; Li H; Luo Y
Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):588-90. PubMed ID: 9275471
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
3. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
Morii K; Tanaka R; Onda K; Tsumanuma I; Yoshimura J
Biochem Biophys Res Commun; 1997 Oct; 239(3):830-4. PubMed ID: 9367854
[TBL] [Abstract][Full Text] [Related]
4. Allelotype of human malignant astrocytoma.
Fults D; Pedone CA; Thomas GA; White R
Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510
[TBL] [Abstract][Full Text] [Related]
5. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Hsu CP; Miaw J; Shai SE; Chen CY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
[TBL] [Abstract][Full Text] [Related]
6. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of telomeric length in epithelial carcinoma of the ovary].
Aldea AI; Barnadas A; Tarrats A; Vaquero M; Muñoz C; Krugger M; Monzó M; Rosell R
Med Clin (Barc); 1998 May; 110(15):561-5. PubMed ID: 9650198
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
9. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
10. Alterations in brain tumor DNA detected by a fingerprinting probe.
Joshi AR; Sinha S; Dil-Afroz ; Sulaiman IM; Banerji AK; Hasnain SE
Indian J Biochem Biophys; 1996 Dec; 33(6):455-7. PubMed ID: 9219429
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
14. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
16. Telomere length in normal and neoplastic canine tissues.
Cadile CD; Kitchell BE; Newman RG; Biller BJ; Hetler ER
Am J Vet Res; 2007 Dec; 68(12):1386-91. PubMed ID: 18052745
[TBL] [Abstract][Full Text] [Related]
17. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
18. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the IDH1 codon 132 mutation in brain tumors.
Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
